Monday, November 9, 2026
The top medical stories of the day, as they ran.
Morning edition
8 stories
- 1Community and EMS training did not improve cardiac arrest survivalResearch · 3 outlets
- 2PAHO to review U.S. measles elimination status amid outbreaksInfectious disease · 2 outlets
- 3Democrats won midterm races as younger candidates and public health leaders gained seatsPublic health · 3 outlets
- 4Trials find retatrutide eased knee osteoarthritis pain in people with obesityResearch · 3 outlets
- 5Left bundle-branch pacing outperforms right ventricular pacing in trialHeart health · 3 outlets
- 6Trial finds stopping statins may be reasonable for some older adultsResearch · 2 outlets
- 7Acorn crops can predict increases in Lyme-carrying ticks two years laterResearch · 2 outlets
- 8Houston Rx recalls compounded sermorelin and tirzepatide productsDrug safety · 1 outlet
Evening edition
16 stories
- 1FDA requires GLP-1 makers to add warning about rare vision lossDrug safety · 9 outlets
- 2Lilly’s oral GLP-1 pill reduced sleep apnea in phase 3 trialsDrugs and FDA · 6 outlets
- 3FDA approves Bayer’s Sunharbo to reduce stroke risk in certain adultsDrugs and FDA · 3 outlets
- 4Former RFK Jr. adviser accuses Trump aides of sidelining health agendaHealth policy · 4 outlets
- 5Community and EMS training did not improve cardiac arrest survivalResearch · 2 outlets
- 6Trump administration announces $10B in rural health awardsHealth policy · 2 outlets
- 7England commits £40 million for GPs to support vulnerable patients this winterPrimary care · 3 outlets
- 8Wisconsin and New York report measles deaths involving infantsInfectious disease · 1 outlet
- 9U.S. imposes new rules on ordering synthetic DNA to deter bioterrorismHealth policy · 2 outlets
- 10Study links early-pregnancy doxycycline use to higher risk of pregnancy lossResearch · 2 outlets
- 11Left bundle-branch pacing lowered composite cardiac events in OptimPacing trialHeart health · 3 outlets
- 12Vir’s hepatitis D drug combination succeeds in first Phase 3 studyDrugs and FDA · 2 outlets
- 13Yoga-based cardiac rehab improved quality of life in heart failure trialResearch · 2 outlets
- 14FDA approves pirtobrutinib for relapsed or refractory mantle cell lymphomaDrugs and FDA · 1 outlet
- 15FDA grants accelerated approval to pirtobrutinib for CLL and SLLDrugs and FDA · 1 outlet
- 16Acorn crops can predict increases in Lyme-carrying ticks two years laterResearch · 2 outlets